Copyright
©The Author(s) 2019.
World J Gastroenterol. Jan 21, 2019; 25(3): 388-397
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.388
Published online Jan 21, 2019. doi: 10.3748/wjg.v25.i3.388
Figure 3 Pre-and post-therapeutic quality of life, as measured by the Gastrointestinal Quality of Life Index, for both groups.
Group A after laparoscopic antireflux surgery (GIQLI preop: 91; postop 117; P < 0,001) and Group B after continued conservative treatment (GIQLI pre: 96; post: 98; P = 0.8279). In the surgical group, GIQLI could be significantly increased. GIQLI: Gastrointestinal Quality of Life Index.
- Citation: Fuchs HF, Babic B, Fuchs KH, Breithaupt W, Varga G, Musial F. Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery? World J Gastroenterol 2019; 25(3): 388-397
- URL: https://www.wjgnet.com/1007-9327/full/v25/i3/388.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i3.388